Literature DB >> 21840552

Comparison of different metabolic syndrome definitions and risks of incident cardiovascular events in the elderly.

Celeste M Vinluan1, Hala H Zreikat, James R Levy, Kai I Cheang.   

Abstract

The metabolic syndrome is associated with increased cardiovascular risk, and its prevalence increases with age. Various definitions of the metabolic syndrome exist, but whether some definitions are more predictive of future cardiovascular events in the elderly is unclear. We compared the risk of incident cardiovascular events in elderly individuals at least 65 years old from the Cardiovascular Health Study with and without the metabolic syndrome as defined by the European Group for the Study of Insulin Resistance (EGIR), National Cholesterol Education Program (NCEP)/American Heart Association (AHA), American Association of Clinical Endocrinologists, International Diabetes Federation (IDF), and modified World Health Organization (WHO) criteria (n = 3390). Participants were without baseline diabetes or cardiovascular disease. Except for EGIR, all definitions of the metabolic syndrome were significantly associated with increased risk of incident cardiovascular (coronary or cerebrovascular) events. Adjusted hazard ratios (HRs) for risk of incident cardiovascular events as defined by the modified WHO, NCEP/AHA, American Association of Clinical Endocrinologists, and IDF criteria ranged from 1.153 (P = .045) for NCEP/AHA to 1.314 (P < .001) for IDF, with 95% confidence interval (CI) ranging from 1.003 to 1.503. Adjusted HR for EGIR was 1.087 (95% CI, 0.908-1.301; P = .362). Similarly, all definitions of the metabolic syndrome were significantly associated with incident coronary events except for the EGIR definition. Only the modified WHO definition was associated with increased risk for cerebrovascular events (adjusted HR, 1.301; 95% CI, 1.038-1.631; P = .022). Although all metabolic syndrome definitions except EGIR were associated with total cardiovascular events and coronary events, only the modified WHO definition was also associated with risk of cerebrovascular events. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21840552      PMCID: PMC3218249          DOI: 10.1016/j.metabol.2011.07.002

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  35 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.

Authors:  Hanna-Maaria Lakka; David E Laaksonen; Timo A Lakka; Leo K Niskanen; Esko Kumpusalo; Jaakko Tuomilehto; Jukka T Salonen
Journal:  JAMA       Date:  2002-12-04       Impact factor: 56.272

Review 3.  American College of Endocrinology position statement on the insulin resistance syndrome.

Authors:  Daniel Einhorn; Gerald M Reaven; Rhoda H Cobin; Earl Ford; Om P Ganda; Yehuda Handelsman; Richard Hellman; Paul S Jellinger; David Kendall; Ronald M Krauss; Naomi D Neufeld; Steven M Petak; Helena W Rodbard; John A Seibel; Donald A Smith; Peter W F Wilson
Journal:  Endocr Pract       Date:  2003 May-Jun       Impact factor: 3.443

4.  Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

Authors:  E Bonora; G Targher; M Alberiche; R C Bonadonna; F Saggiani; M B Zenere; T Monauni; M Muggeo
Journal:  Diabetes Care       Date:  2000-01       Impact factor: 19.112

5.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

6.  Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study.

Authors:  Enzo Bonora; Stefan Kiechl; Johann Willeit; Friedrich Oberhollenzer; Georg Egger; Riccardo C Bonadonna; Michele Muggeo
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

7.  NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older.

Authors:  Charles M Alexander; Pamela B Landsman; Steven M Teutsch; Steven M Haffner
Journal:  Diabetes       Date:  2003-05       Impact factor: 9.461

8.  Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.

Authors:  Shaista Malik; Nathan D Wong; Stanley S Franklin; Tripthi V Kamath; Gilbert J L'Italien; Jose R Pio; G Rhys Williams
Journal:  Circulation       Date:  2004-08-23       Impact factor: 29.690

9.  The metabolic syndrome and coronary heart disease in older women: findings from the British Women's Heart and Health Study.

Authors:  D A Lawlor; S Ebrahim; G Davey Smith
Journal:  Diabet Med       Date:  2004-08       Impact factor: 4.359

10.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.

Authors:  K G M M Alberti; Robert H Eckel; Scott M Grundy; Paul Z Zimmet; James I Cleeman; Karen A Donato; Jean-Charles Fruchart; W Philip T James; Catherine M Loria; Sidney C Smith
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

View more
  18 in total

1.  Effect of Renin-Angiotensin system inhibition on cardiovascular events in older hypertensive patients with metabolic syndrome.

Authors:  Hala H Zreikat; Spencer E Harpe; Patricia W Slattum; D'arcy P Mays; Paulina A Essah; Kai I Cheang
Journal:  Metabolism       Date:  2013-11-16       Impact factor: 8.694

2.  An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score.

Authors:  Matthew J Gurka; Christa L Lilly; M Norman Oliver; Mark D DeBoer
Journal:  Metabolism       Date:  2013-10-24       Impact factor: 8.694

3.  Antihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly mild to moderate essential hypertensive patients with or without metabolic syndrome: a pooled post hoc analysis of two comparative trials.

Authors:  Stefano Omboni; Ettore Malacco; Jean-Michel Mallion; Massimo Volpe
Journal:  Drugs Aging       Date:  2012-12       Impact factor: 3.923

4.  Cerebral blood flow and cognitive function in patients with metabolic syndrome: effect of antihypertensive therapy.

Authors:  Irina Efimova; Natalya Efimova; Yuri Lishmanov
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-11-10       Impact factor: 3.738

5.  Comparisons of different metabolic syndrome definitions and associations with coronary heart disease, stroke, and peripheral arterial disease in a rural Chinese population.

Authors:  Jiangping Wen; Jingang Yang; Yujie Shi; Yuanbo Liang; Fenghua Wang; Xinrong Duan; Xilin Lu; Qiushan Tao; Xinxin Lu; Yaping Tian; Ningli Wang
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

6.  All-cause mortality and serious cardiovascular events in people with hip and knee osteoarthritis: a population based cohort study.

Authors:  Gillian A Hawker; Ruth Croxford; Arlene S Bierman; Paula J Harvey; Bheeshma Ravi; Ian Stanaitis; Lorraine L Lipscombe
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

7.  A prospective study of risk factors for cardiovascular events among the elderly.

Authors:  Marcos Aparecido Sarria Cabrera; Selma Maffei de Andrade; Arthur Eumann Mesas
Journal:  Clin Interv Aging       Date:  2012-11-01       Impact factor: 4.458

8.  Which insulin resistance-based definition of metabolic syndrome has superior diagnostic value in detection of poor health-related quality of life? Cross-sectional findings from Tehran Lipid and Glucose Study.

Authors:  Tina Deihim; Parisa Amiri; Reza Taherian; Maryam Tohidi; Asghar Ghasemi; Leila Cheraghi; Fereidoun Azizi
Journal:  Health Qual Life Outcomes       Date:  2015-12-09       Impact factor: 3.186

9.  Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study.

Authors:  Maria Angeles Via-Sosa; Cristina Toro; Pere Travé; Marian A March
Journal:  BMC Public Health       Date:  2014-05-22       Impact factor: 3.295

10.  Gender differences in metabolic syndrome components among the Korean 66-year-old population with metabolic syndrome.

Authors:  Sangjin Lee; Young Ko; Chanyeong Kwak; Eun-Shil Yim
Journal:  BMC Geriatr       Date:  2016-01-23       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.